Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.

Oncogene 2019 Sep 29;38(38):6507-6520. Epub 2019 Jul 29.

Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, CA, 91010-3000, USA.

Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown. In addition, there are no biologically relevant models that can be used to assess the molecular mechanisms for these genetic abnormalities. Here, we report a novel mouse model, in which elevated transgenic AR expression and Trp53 deletion occur simultaneously in mouse prostatic epithelium to mimic human prostate cancer cells. These compound mice developed an earlier onset of high-grade prostatic intraepithelial neoplasia and accelerated prostate tumors in comparison with mice harboring only the AR transgene. Histological analysis showed prostatic sarcomatoid and basaloid carcinomas with massive squamous differentiation in the above compound mice. RNA-sequencing analyses identified a robust enrichment of the signature genes for human prostatic basal cell carcinomas in the above prostate tumors. Master regulator analysis revealed SOX2 as a transcriptional regulator in prostatic basal cell tumors. Elevated expression of SOX2 and its downstream target genes were detected in prostatic tumors of the compound mice. Chromatin immunoprecipitation analyses implicate a coregulatory role of AR and SOX2 in the expression of prostatic basal cell signature genes. Our data demonstrate a critical role of SOX2 in prostate tumorigenesis and provide mechanistic insight into prostate tumor aggressiveness and progression mediated by aberrant AR and p53 signaling pathways.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-0901-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752978PMC
September 2019
2 Reads

Publication Analysis

Top Keywords

compound mice
12
prostatic basal
12
basal cell
12
prostate
9
prostate tumors
8
role sox2
8
prostate cancer
8
signature genes
8
human prostate
8
prostate tumorigenesis
8
prostatic
7
carcinomas massive
4
basaloid carcinomas
4
prostatic sarcomatoid
4
analysis prostatic
4
massive squamous
4
sarcomatoid basaloid
4
mice rna-sequencing
4
robust enrichment
4
enrichment signature
4

References

(Supplied by CrossRef)

N Kyprianou et al.
Endocrinology 1988

C Huggins et al.
J Urol 2002

C Zhu et al.
J Biol Chem 2011

CA Heinlein et al.
Endocr Rev 2004

D Robinson et al.
Cell 2015

DA Quigley et al.
Cell 2018

P Koivisto et al.
Cancer Res 1997

R Aggarwal et al.
J Clin Oncol 2018

CD Chen et al.
Nat Med 2004

DY Takeda et al.
Cell 2018

LJ Ko et al.
Genes Dev 1996

Similar Publications